Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders

N Nicosia, M Giovenzana, P Misztak… - International Journal of …, 2024 - mdpi.com
Glutamate is the main excitatory neurotransmitter in the brain wherein it controls cognitive
functional domains and mood. Indeed, brain areas involved in memory formation and …

The Clinical Potential of Dimethyltryptamine: Breakthroughs into the Other Side of Mental Illness, Neurodegeneration, and Consciousness

FA Colosimo, P Borsellino, RI Krider, RE Marquez… - Psychoactives, 2024 - mdpi.com
The human brain is an extraordinarily complex organ responsible for all aspects of cognition
and control. Billions of neurons form connections with thousands of other neurons, resulting …

Neurobiologie und Wirkmodelle zu Psychedelika

U Herwig, M Avram, S Borgwardt… - Nervenheilkunde, 2024 - thieme-connect.com
Zur Beantwortung der Frage, ob Psychedelika eine therapeutische Wirkung bei psychischen
Erkrankungen aufweisen, ist entscheidend, sich mit möglichen Wirkmechanismen …

[HTML][HTML] Neurotransmitters: Roles, Functions, and Impact on Mental Health

M Electricwala - Mave Health. Retrieved September, 2024 - mavehealth.com
Conclusion Neurotransmitters are fundamental to maintaining brain health and overall well-
being. Their roles in communication, mood regulation, cognition, and behaviour underscore …

The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents

AA Jensen, CR Cecchi, M Hibicke, AH Bach, E Kaadt… - bioRxiv, 2024 - biorxiv.org
Psychedelic-assisted psychotherapy has over the last decade emerged as a promising
treatment strategy for mental health disease, and the therapeutic potential in classical …

Invited Commentary on Psychedelic Therapy: A Primer for Primary Care Clinicians

LM Morski - American Journal of Therapeutics, 2024 - journals.lww.com
Despite psychedelic substances being banned for decades, determined researchers in the
1990s and 2000s rekindled the study of psychedelic substances in preclinical and clinical …

Souvislost psychedelické zkušenosti a vybraných psychologických fenoménů

R Kočárová - 2024 - dspace.cuni.cz
Předkládaná disertační práce zpracovává téma zkušenosti s užitím klasických psychedelik
(tj. syntetický nebo přirozeně se vyskytující psilocybin, LSD, DMT, 5-MeO-DMT a mezkalin) v …

[PDF][PDF] A proposed strategy to improve GLP-1 agonist use: financial cost and pharmacological efficacy

WC Santos - Actualidad en farmacología y terapéutica, 2024 - researchgate.net
The glucagon like peptide (GLP-1) agonists such as liraglutide, semaglutide, or tirzepatide
were first approved for the treatment of type 2 diabetes, but now they are also approved in …

[PDF][PDF] La psilocibina un mecanismo de acción complejo entre droga psicodélica y neuropsicofármaco

C Álamo - socesfar.es
La psilocibina es una triptamina fosforilada, que está presente en más de 200 especies de
hongos, la mayoría del género Psilocybe, conocidos como “hongos o setas mágicas”, con …